FIELD: organic chemistry.
SUBSTANCE: invention relates to 4-amino-5-phenyl-7-cyclobutylpyrrolo[2,3-d]pyrimidine derivatives of general formula I 
wherein meanings of R1, R2, R4, and X are as described in the disclosure, and salts thereof. Said derivatives are capable to inhibit IGR-IR tyrosin kinase activity and are useful in production of pharmaceutical composition for treatment of proliferative decisions. Pharmaceutical composition based on abovementioned derivatives and method for production thereof also are disclosed.
EFFECT: new derivatives for treatment of proliferative decisions.
9 cl, 134 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF 4-AMINO-6-PHENYLPYRROLO[2,3]PYRIMIDINE POSSESSING INHIBITORY EFFECT ON TYROSINE KINASE ACTIVITY, THEIR USING AND METHODS FOR THEIR PREPARING (VARIANTS) | 2002 |
|
RU2318826C2 |
| 6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEINKINASE INHIBITORS | 2005 |
|
RU2379308C2 |
| JAK INHIBITORS | 2010 |
|
RU2538204C2 |
| 5-(7H-PYRROLO[2,3-d]PYRIMIDINE-4-YL)-5-AZASPIRO[2.5]OCTANE-8-CARBOXYLIC ACID DERIVATIVES AS NEW JAK-KINASE INHIBITORS | 2018 |
|
RU2761626C2 |
| IMIDAZOPYRAZINES AS TYROSINE KINASE INHIBITORS | 2004 |
|
RU2405784C2 |
| 1,5-NAPHTHRIDINE DERIVATIVES AND MELK INHIBITORS CONTAINING THEM | 2012 |
|
RU2645339C1 |
| PYRROLOPYRIMIDINE COMPOUNDS FOR MALIGNANT TUMOUR TREATMENT | 2012 |
|
RU2631655C2 |
| HETEROARYL COMPOUNDS, THEIR COMPOSITIONS AND USE THEREOF AS PROTEIN KINASE INHIBITORS | 2007 |
|
RU2474582C2 |
| TRICYCLIC JANUS KINASE 1 INHIBITORS, COMPOSITIONS, METHODS OF PRODUCTION AND USE THEREOF | 2019 |
|
RU2824349C2 |
| 4-AMINOPYPERIDINE DERIVATIVES | 2005 |
|
RU2396257C2 |
